Paper: Effect of airway disease on drug deposition in the lung
Chantal Darquenne is a Professor in the Division of Pulmonary, Critical Care and Sleep Medicine (section of Physiology) at the University of California, San Diego (UCSD) and the current immediate past-President of the International Society of Aerosols in Medicine (ISAM). She earned her Ph.D. degree in Applied Sciences from the Université Libre de Bruxelles (Belgium) in 1995 and completed a postdoctoral fellowship in the Division of Physiology at UCSD. Dr. Darquenne serves as an Associate Editor of the ISAM Textbook of Aerosol Medicine and is a member of the editorial board of the Journal of Aerosol Medicine and Pulmonary Drug Delivery, the Journal of Aerosol Science and the Journal of Applied Physiology. Her research and publications have focused on the fate of inhaled aerosols in the human lung with applications both in toxic effects of airborne particulate matter and in therapeutic effects of inhaled pharmaceutical aerosols, and also on lung ventilation inhomogeneities in health and disease. Her major research contributions in the field include the study of aerosol inhalations in humans in altered gravity, the development of numerical models that simulate the transport and deposition of aerosols in the lung, the effect of lung disease on both regional and overall aerosol deposition, and the study of upper airway dynamics during breathing and its effect on aerosol transport. Her research is mainly funded through awards and contracts with the National Institute of Health (United States) and with the US Environmental Protection Agency. Dr. Darquenne is a fellow of ISAM.